SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp (Last) (First) (Middle) 1668 S. GARFIELD AVE. 2ND FLOOR (Street) ALHAMBRA CA 91801 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Apollo Medical Holdings, Inc. [ AMEH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 12/07/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/07/2022		M		55,337	A	$10	10,246,997(1)	D
Common Stock	12/07/2022		M		52,262	A	$11	10,299,259(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants to purchase Common Stock	$10	12/07/2022		M			55,337.13	12/08/2017	12/08/2022	Common Stock	55,337.13	(2)	0	D
Warrants to purchase Common Stock	$11	12/07/2022		M			52,262.84	12/08/2017	12/08/2022	Common Stock	52,262.84	(2)	0	D

1. Name and Address of Reporting Person* ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp (Last) (First) (Middle) 1668 S. GARFIELD AVE. 2ND FLOOR (Street) ALHAMBRA CA 91801 (City) (State) (Zip)

1. Name and Address of Reporting Person* Lam Thomas S. (Last) (First) (Middle) 1668 GARFIELD AVE., 2ND FLOOR (Street) ALHAMBRA CA 91801 (City) (State) (Zip)

1. Name and Address of Reporting Person* Sim Kenneth T. (Last) (First) (Middle) 1668 S. GARFIELD AVE. 2ND FLOOR (Street) ALHAMBRA CA 91801 (City) (State) (Zip)

1. Name and Address of Reporting Person* Young Albert WaiChow (Last) (First) (Middle) 1668 S. GARFIELD AVE. 2ND FLOOR (Street) ALHAMBRA CA 91801 (City) (State) (Zip)

Explanation of Responses:

1. These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

2. On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

	/s/ Thomas S. Lam, Chief Executive Officer	12/09/2022
	/s/ Thomas S. Lam	12/09/2022
	/s/ Kenneth T. Sim	12/09/2022
	/s/ Albert WaiChow Young	12/09/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.